Home

Stock Information

Stock Quote | Stock Chart | Historical Price Lookup | Investment Calculator
TNGN (Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.09
Change (%)0.00 (0.00%)
Volume36,900
Today's Open$0.08
Previous Close$0.09
Intraday High$0.09
Intraday Low$0.08
52 Week High$0.80
52 Week Low$0.07
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Minimum 20 minutes delayed
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.09
Change (%)0.00 (0.00%)
Volume36,900
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
August 13, 2014
Tengion Provides Clinical Update and Reports Second Quarter 2014 Financial Results
WINSTON-SALEM, N.C., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported key clinical data along with financial and operating results for the quarter ended June 30, 2014. "Today, we are pleased to announce encouraging six-month interim data for the first five patients implanted in the Phase 1 clinical trial of our Neo-Kidney Augment (NKA) cellular therapy being conducted in Sweden. We believe these early trends support the promising... 
May 15, 2014
Tengion Reports First Quarter 2014 Financial Results
WINSTON-SALEM, N.C., May 15, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the first quarter ended March 31, 2014. "We are actively continuing patient enrollment in our ongoing Phase 1 clinical trials for the Neo-Kidney Augment in both Sweden and in the United States. We are also working with key opinion leaders to determine future development plans for the Neo-Urinary Conduit," commented John L. Miclot, Presi...